Desmoplastic melanoma: Expression of epithelial-mesenchymal transition-related proteins

American Journal of Dermatopathology

Volumn 36, Issue 3, 2014, Pages 238-242

  Concepción Garrido, Maria ^a   Requena, Luis ^b   Kutzner, Heinz ^c   Ortiz, Pablo ^a   Pérez Gómez, Beatriz ^d   Rodriguez Peralto, José Luis ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Dermatopathologie Bodensee   (Germany)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Desmoplastic melanoma; Epithelial'mesenchymal transition; N cadherin; SPARC; WT1

Indexed keywords

CELL PROTEIN; EPITHELIAL MESENCHYMAL TRANSITION RELATED PROTEIN; MELAN A; NERVE CELL ADHESION MOLECULE; OSTEONECTIN; PROTEIN KINASE C ALPHA; PROTEIN S 100; UNCLASSIFIED DRUG; UVOMORULIN; WT1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; DESMOPLASTIC MELANOMA; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GROWTH CURVE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY; TUMOR CELL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84897110730     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182987441     Document Type: Article

References (20)

1. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871-890
2. Alonso SR, Tracey L, Ortiz P, et al. A high-Throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 2007;67:3450-3460
3. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplastic neurotropic melanoma: Experience with 280 patients. Cancer. 1998;83:1128-1135
4. Carlson JA, Dickersin GR, Sober AJ, et al. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer. 1995;75: 478-494
5. Jain S, Allen PW. Desmoplastic malignant melanoma and its variants. A study of 45 cases. Am J Surg Pathol. 1989;13:358-373
6. Hawkins WG, Busam KJ, Ben-Porat L, et al. Desmoplastic melanoma: A pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol. 2005;12:207-213
7. Busam KJ, Zhao H, Coit DG, et al. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling. J Invest Dermatol. 2005;124:412-418
8. Scolyer RA, Thompson JF. Desmoplastic melanoma: A heterogeneous entity in which subclassification as pureor mixedmay have important prognostic significance. Ann Surg Oncol. 2005;12:197-199
9. Attis MG, Burchette JL, Selim MA, et al. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas. Hum Pathol. 2006;37:899-905
10. Hilliard NJ, Krahl D, Sellheyer K. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma. J Cutan Pathol. 2009;36:753-759
11. Iwamoto S, Odland PB, Piepkorn M, et al. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol. 1996;35(5 pt 1):725-731
12. Leinweber B, Hofmann-Wellenhof R, Kaddu S, et al. Procollagen 1 and melan-A expression in desmoplastic melanomas. Am J Dermatopathol. 2009;31:173-176
13. Radfar A, Stefanato CM, Ghosn S, et al. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas. Am J Dermatopathol. 2006; 28:162-167
14. Busam KJ, Mujumdar U, Hummer AJ, et al. Cutaneous desmoplastic melanoma: Reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol. 2004;28:1518-1525
15. Skelton HG, Smith KJ, Laskin WB, et al. Desmoplastic malignant melanoma. J Am Acad Dermatol. 1995;32(5 pt 1):717-725
16. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-Throughput molecular profiling of tumor specimens. Nat Med. 1998; 4:844-847
17. Garrido-Ruiz MC, Rodriguez-Pinilla SM, Perez-Gomez B, et al. WT 1 expression in nevi and melanomas: A marker of melanocytic invasion into the dermis. J Cutan Pathol. 2010;37:542-548
18. Prada F, Benedetti LG, Bravo AI, et al. SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth. J Invest Dermatol. 2007;127:2618-2628
19. Martinez-Estrada OM, Lettice LA, Essafi A, et al. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet. 2010;42:89-93
20. Alonso-Magdalena P, Brossner C, Reiner A, et al. A role for epithelialmesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci U S A. 2009;106:2859-2863.